File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Controversies in the treatment of carcinoma of cervix

TitleControversies in the treatment of carcinoma of cervix
Authors
KeywordsCervical Cancer
Chemotherapy
Radiotherapy
Surgery
Issue Date1992
Citation
Journal Of The Hong Kong Medical Association, 1992, v. 44 n. 4, p. 244-247 How to Cite?
AbstractCarcinoma of the cervix is the most common female lower genital tract cancer in Hong Kong. Traditional treatment of early stage disease by radiotherapy or surgery or combination of both showed a 5-year survival rate of 80%-85%. However, there are subgroups of early stage patients which do better and subgroups that do worse. Hence, there has been controversy as to whether one should use more conservative treatment for the former group (stage Iai cervical cancer) and adopt a more aggressive approach in the latter group (stage Iaii and Ib disease with poor prognostic factors). In this article, the following controversies are discussed: (1) the treatment of stage Iai and stage Iaii cervical cancer; (2) treatment for subgroup of stage Ib cervical cancer with poor prognostic factors; (3) the usefulness of post-operative radiotherapy in patients with early stage cervical cancer who had positive pelvic nodes; and (4) adjuvant therapy in advanced and recurrent cervical cancer. Multicentre control trials are called for to settle some of these controversies.
Persistent Identifierhttp://hdl.handle.net/10722/173181
ISSN

 

DC FieldValueLanguage
dc.contributor.authorNgan, HYSen_US
dc.date.accessioned2012-10-30T06:28:22Z-
dc.date.available2012-10-30T06:28:22Z-
dc.date.issued1992en_US
dc.identifier.citationJournal Of The Hong Kong Medical Association, 1992, v. 44 n. 4, p. 244-247en_US
dc.identifier.issn1010-8424en_US
dc.identifier.urihttp://hdl.handle.net/10722/173181-
dc.description.abstractCarcinoma of the cervix is the most common female lower genital tract cancer in Hong Kong. Traditional treatment of early stage disease by radiotherapy or surgery or combination of both showed a 5-year survival rate of 80%-85%. However, there are subgroups of early stage patients which do better and subgroups that do worse. Hence, there has been controversy as to whether one should use more conservative treatment for the former group (stage Iai cervical cancer) and adopt a more aggressive approach in the latter group (stage Iaii and Ib disease with poor prognostic factors). In this article, the following controversies are discussed: (1) the treatment of stage Iai and stage Iaii cervical cancer; (2) treatment for subgroup of stage Ib cervical cancer with poor prognostic factors; (3) the usefulness of post-operative radiotherapy in patients with early stage cervical cancer who had positive pelvic nodes; and (4) adjuvant therapy in advanced and recurrent cervical cancer. Multicentre control trials are called for to settle some of these controversies.en_US
dc.languageengen_US
dc.relation.ispartofJournal of the Hong Kong Medical Associationen_US
dc.subjectCervical Canceren_US
dc.subjectChemotherapyen_US
dc.subjectRadiotherapyen_US
dc.subjectSurgeryen_US
dc.titleControversies in the treatment of carcinoma of cervixen_US
dc.typeArticleen_US
dc.identifier.emailNgan, HYS:hysngan@hkucc.hku.hken_US
dc.identifier.authorityNgan, HYS=rp00346en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.scopuseid_2-s2.0-0026979432en_US
dc.identifier.volume44en_US
dc.identifier.issue4en_US
dc.identifier.spage244en_US
dc.identifier.epage247en_US
dc.publisher.placeHong Kongen_US
dc.identifier.scopusauthoridNgan, HYS=34571944100en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats